About Enterobiotix
Enterobiotix is a company based in Edinburgh (United Kingdom) founded in 2017.. Enterobiotix has raised $72.96 million across 10 funding rounds from investors including Syndicate Room, Scottish Enterprise and NCIMB. The company has 65 employees as of December 31, 2023. Enterobiotix offers products and services including EBX-102-02 and IMT Therapies. Enterobiotix operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, DermBiont and Cosmo Pharmaceuticals, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 65 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enterobiotix Limited
- Date of Incorporation 02 Mar, 2017
- Jurisdiction GLASGOW, SCOTLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$72.96 M (USD)
in 10 rounds
-
Latest Funding Round
-
Investors
Syndicate Room
& 11 more
-
Employee Count
65
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enterobiotix
Enterobiotix offers a comprehensive portfolio of products and services, including EBX-102-02 and IMT Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for irritable bowel syndrome via gut restoration
Therapies to restore and enhance gut microbial ecology
Unlock access to complete
Unlock access to complete
Funding Insights of Enterobiotix
Enterobiotix has successfully raised a total of $72.96M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Last Round
-
First Round
First Round
(21 Jun 2017)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2026 | Amount | Series B - Enterobiotix | Valuation |
investors |
Thairm Bio ,
The Scottish National Investment Bank
|
| Mar, 2026 | Amount | Series B - Enterobiotix | Valuation |
investors |
|
| Jul, 2025 | Amount | Series B - Enterobiotix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enterobiotix
Enterobiotix has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Syndicate Room, Scottish Enterprise and NCIMB. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on social impact companies
|
Founded Year | Domain | Location | |
|
Angel investment funding is facilitated for early-stage Scottish businesses.
|
Founded Year | Domain | Location | |
|
Early-stage investment is provided to promising Scottish entrepreneurs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enterobiotix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enterobiotix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enterobiotix Comparisons
Competitors of Enterobiotix
Enterobiotix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, DermBiont and Cosmo Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enterobiotix
Frequently Asked Questions about Enterobiotix
When was Enterobiotix founded?
Enterobiotix was founded in 2017.
Where is Enterobiotix located?
Enterobiotix is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Is Enterobiotix a funded company?
Enterobiotix is a funded company, having raised a total of $72.96M across 10 funding rounds to date. The company's 1st funding round was a Series B of $1.39M, raised on Jun 21, 2017.
How many employees does Enterobiotix have?
As of Dec 31, 2023, the latest employee count at Enterobiotix is 65.
What does Enterobiotix do?
Enterobiotix was founded in 2017 in Edinburgh, United Kingdom, within the biotechnology sector. Focus is placed on microbiome-based therapeutics targeting multiple diseases, especially those affecting the gut like Inflammatory Bowel Disease. An integrated anaerobic system is under development, featuring a closed benchtop setup for collection and processing that supports therapy production in anaerobic conditions without cleanrooms. Operations aim to deliver these treatments to patients through controlled, non-sterile environments.
Who are the top competitors of Enterobiotix?
Enterobiotix's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
What products or services does Enterobiotix offer?
Enterobiotix offers EBX-102-02 and IMT Therapies.
Who are Enterobiotix's investors?
Enterobiotix has 12 investors. Key investors include Syndicate Room, Scottish Enterprise, NCIMB, University of Aberdeen, and Kineticos.